Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 23 M26 M27 M27 M25 M29 M 108 M Research & development —————— — Operating income 18 M6 M26 M-3 M24 M72 M 119 M Non-Operating Income, Total -17 M-19 M-26 M-36 M-8 M-31 M -101 M Interest expense, net of interest capitalized 15 M15 M15 M24 M15 M16 M 70 M Non-Operating Income, excl. Interest Expenses -3 M-6 M-37 M-50 M-24 M-24 M -135 M Unusual income/expense -14 M-13 M-4 M-10 M1 M-23 M -36 M Pretax income 1 M-13 M0-39 M16 M41 M 18 M Equity in earnings 8 M6 M-11 M-13 M4 M4 M -16 M Taxes 15 M29 M11 M-29 M23 M12 M 17 M Non-controlling/minority interest —————— — After tax other income/expense -12 M-15 M04 M00 4 M Net income before discontinued operations -14 M-42 M-11 M-10 M-7 M29 M 1 M Discontinued operations —————— — Net income -14 M-42 M-11 M-10 M-7 M29 M 1 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -13 M-41 M-10 M-8 M-6 M31 M 7 M Basic earnings per share (Basic EPS) -0.23-0.68-0.17—-0.110.47 — Diluted earnings per share (Diluted EPS) -0.23-0.68-0.17-0.15-0.110.47 0.04 Average basic shares outstanding 62 M62 M62 M62 M62 M62 M — Diluted shares outstanding 65 M65 M65 M65 M65 M65 M — EBITDA 73 M62 M84 M87 M95 M144 M 410 M EBIT 18 M6 M26 M18 M24 M72 M 140 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 55 M56 M58 M69 M71 M72 M 270 M